| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 81 |
| 1 | OCTREOTIDE ACETATE | 38 |
| 2 | PREDNISONE | 38 |
| 3 | METHOTREXATE SODIUM | 34 |
| 4 | CYCLOPHOSPHAMIDE | 33 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 33 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 33 |
| 7 | RITUXIMAB | 33 |
| 8 | METHOTREXATE | 32 |
| 9 | DOXORUBICIN | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MECLOFENAMATE SODIUM | 1 | 0.0182 |
| 1 | SHARK CARTILAGE | 1 | 0.0119 |
| 2 | MOISTURIZER | 1 | 0.0083 |
| 3 | GABA (GAMMA-AMINOBUTYRIC ACID) | 1 | 0.0047 |
| 4 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 5 | VINORELBINE | 9 | 0.0013 |
| 6 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 7 | OCTREOTIDE ACETATE | 38 | 0.0012 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 9 | NIRAPARIB | 27 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 79 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 66 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 57 |
| 3 | Kinase Inhibitor [EPC] | 55 |
| 4 | Alkylating Drug [EPC] | 39 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 38 |
| 6 | Platinum-based Drug [EPC] | 35 |
| 7 | Benzodiazepine [EPC] | 33 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Progestin Antagonist [EPC] | 4 | 0.0008 |
| 2 | Somatostatin Analog [EPC] | 5 | 0.0007 |
| 3 | Provitamin D2 Compound [EPC] | 20 | 0.0007 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 6 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 7 | Actinomycin [EPC] | 1 | 0.0005 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |